|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A01N 65/00 | |
| A61K 36/47 | |||
| A61K 36/38 |
| (11) | Number of the document | 2529626 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12182318.1 |
| Date of filing the European patent application | 2007-04-30 | |
| (97) | Date of publication of the European application | 2012-12-05 |
| (45) | Date of publication and mention of the grant of the patent | 2017-11-22 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 797075 P | 2006-05-01 | US |
| (72) |
Quart, Barry, US
|
| (73) |
Napo Pharmaceuticals, Inc.,
201 Mission Street, Suite 2375, San Francisco, CA 94105,
US
|
| (54) | Compositions and methods for treating or preventing colon cancer |
| Compositions and methods for treating or preventing colon cancer |